#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Asthma Dermatitis atopic Dementia Alzheimer's type Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    B-cell small lymphocytic lymphoma recurrent Pulmonary arterial hypertension Wiskott-Aldrich syndrome Behcet's syndrome Chronic lymphocytic leukaemia refractory Chondrosarcoma metastatic Ehlers-Danlos syndrome Congenital absence of bile ducts Hyperphagia Sarcoidosis Intracranial germ cell tumour Hyperinsulinaemic hypoglycaemia Systemic mastocytosis Paroxysmal nocturnal haemoglobinuria Retinoblastoma More trials…

    Learn about Rare Diseases

    Glycogen storage disease type V – Trials in Disease Hereditary angioedema Prolymphocytic leukaemia – Life with Disease Behcet’s syndrome – Life with Disease Myelodysplastic syndrome with excess blasts – Treatment Glomerulonephritis rapidly progressive Nephrotic syndrome – Treatment Familial amyotrophic lateral sclerosis – Life with Disease Hairy cell leukaemia recurrent – Treatment Lysosomal storage disorder – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Simoctocog Alfa Iph6501 R3R01 Mk-0616 Epoetin Alfa Immunoglobulin A Artemisia Vulgaris Brexucabtagene Autoleucel GS-4321 Liquid Paraffin Insulin Human Vilobelimab Alnuctamab NAVENIBART AUR200 ALFENTANIL HYDROCHLORIDE Messenger Rna Encoding Cas9 Treprostinil Sodium Lu Ag09222 Acemetacin More therapies…

    Learn about Your Condition

    Acute coronary syndrome Bipolar I disorder Immune system disorder Hereditary ataxia Renal injury Amnestic disorder Uveitis Propionic acidaemia Mantle cell lymphoma stage III Organ donor Colon cancer stage IV Turner's syndrome Retroperitoneal fibrosis Respiratory failure Endometrial stromal sarcoma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Centre Hospitalier Sud Francilien

Centre Hospitalier Sud Francilien

40 Avenue Serge Dassault, Corbeil Essonnes, 91106, France

Want to learn more about this study or check if you can participate? Contact us.

  • Study of inclisiran to prevent heart attacks and strokes in people with atherosclerotic cardiovascular disease

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Arteriosclerosis
    Investigated Drugs:
    • Atorvastatin
    • Rosuvastatin
    • Inclisiran
    Austria Belgium Bulgaria Croatia Czechia Denmark +18

  • Study on Asundexian for Preventing Ischemic Stroke in Adults After a Stroke or High-Risk Mini-Stroke

    Not recruiting

    3 1
    Investigated Drugs:
    • Asundexian
    Austria Belgium Bulgaria Czechia Denmark Finland +14

  • Study on Brentuximab Vedotin, Lenalidomide, and Rituximab for Patients with Relapsed or Refractory Diffuse Large B-cell Lymphoma

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Brentuximab Vedotin
    • Lenalidomide
    • Rituximab
    Belgium Czechia Denmark France Italy Poland +1

  • Study on GnRH Agonists for Ovulation and Luteal Support in IVF Patients: Comparing GnRH Agonist with hCG and Progesterone

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Choriogonadotropin Alfa
    • Nafarelin
    • Progesterone
    France

  • Study on Lenalidomide, Tafasitamab, and Rituximab for Treating Diffuse Large B-Cell Lymphoma in Patients Aged 80 and Older

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    • Tafasitamab
    • Cyclophosphamide
    • Doxorubicin
    Belgium France

  • Study Comparing Chemotherapy with Docetaxel, Cisplatin, and Fluorouracil to Standard Treatment for Patients with Advanced Anal Cancer

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Anal squamous cell carcinoma
    Investigated Drugs:
    • Mitomycin
    • Capecitabine
    • Cisplatin
    France

  • Study on the Impact of Sufentanil Citrate and Remifentanil on Heart Rate During Rapid Sequence Intubation in Patients Over 55 with High Anesthesia Risk

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Remifentanil
    • Sufentanil Citrate
    • Sodium Chloride
    France

  • Study on Secukinumab and Prednisone for Patients with Polymyalgia Rheumatica Who Have Recently Relapsed

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Secukinumab
    • Prednisone
    Belgium Czechia Denmark Finland France Germany +9

  • Study on the Effectiveness of Co-Trimoxazole for Treating Ventilator-Associated Pneumonia in ICU Patients Compared to a Drug Combination

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Pneumonia
    Investigated Drugs:
    • Amoxicillin
    • Amoxicillin Sodium
    • Aztreonam
    France

  • Study on GSK3858279 for Adults with Chronic Diabetic Nerve Pain

    Not recruiting

    2 1
    Investigated Diseases:
    • Diabetic neuropathy
    Investigated Drugs:
    • Gsk3858279
    France Germany Poland Spain
Previous Page
1 … 5 6 7 8
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!